Journal of Transplantation / 2012 / Article / Tab 2

Clinical Study

Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients

Table 2

Urinary NGAL levels (NGAL/creatinine; (ng/g)), and associations with various clinical, laboratory and demographic variables. Results are separately reported for the 6-week and 6-month samples. The remaining variables which were tested without significant differences are reported in the Supplementary Materials.

6 weeks value6 months value
MaleFemaleMaleFemale

Donor gender18,875
( )
23,910
( )
0.3112,264
( )
21,785
( )
0.071
Recipient gender18,242
( )
37,855
( )
0.01111,491
( )
32,613
( )
0.000
GFRa 0.066 0.006

6 weeks value6 months value
Not presentPresentNot presentPresent

Delayed graft function18,875 ( )21,315
( )
0.21817,554
( )
19,354
( )
0.866
Isometric vacuolizationb19,187 ( )31,224
( )
0.03122,436
( )
9,480
( )
0.008
cGrade 0b19,031 ( )39,575
( )
0.03314,218
( )
21,115
( )
0.583
Urinary tract infection at the time of sampling17,901 ( )50,548
( )
0.00013,760
( )
64,889
( )
0.014
Panel reactive antibodies at transplantation 0%22,952
( )
11,696
( )
0.01917,194
( )
33,929
( )
0.342
Blood transfusion before transplantation19,530
( )
25,876
( )
0.44913,286
( )
30,322
( )
0.022
MMF in the initial immunosuppression27,842
( )
19,187
( )
0.24524,208
( )
17,875
( )
0.019
Coronary heart disease before transplantation16,502
( )
21,822
( )
0.11619,354
( )
8,969
( )
0.043

aGFR calculated according to the Cockroft and Gault formula at the time of sampling, baccording to the BANFF classification, at the time of sampling.